View in EDS

353P - Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study.

Saved in:
Bibliographic Details
Title: 353P - Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study.
Authors: Masuda, N.1 (AUTHOR), Ohtani, S.2 (AUTHOR), Nagai, S.3 (AUTHOR), Takashima, S.4 (AUTHOR), Yamaguchi, M.5 (AUTHOR), Tsuneizumi, M.6 (AUTHOR), Komoike, Y.7 (AUTHOR), Osako, T.8 (AUTHOR), Ito, Y.9 (AUTHOR), Ikeda, M.10 (AUTHOR), Ishida, K.11 (AUTHOR), Nakayama, T.12 (AUTHOR), Takashima, T.13 (AUTHOR), Asakawa, T.14 (AUTHOR), Matsumoto, S.15 (AUTHOR), Shimizu, D.16 (AUTHOR), Takahashi, M.17 (AUTHOR)
Source: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv127-v128. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdz242.048